Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AORT Artivion	$39.89 -2.0%	$37.46	$21.97 ▼ $45.07	$1.88B	1.69	441,917 shs	124,466 shs
ENOV Enovis	$32.02 +0.9%	$29.85	$25.47 ▼ $49.83	$1.83B	1.68	1.17 million shs	438,895 shs
EYE National Vision	$23.67 +2.9%	$24.00	$9.56 ▼ $25.67	$1.88B	1.23	2.08 million shs	731,680 shs
KIDS OrthoPediatrics	$19.67 +0.1%	$20.90	$16.59 ▼ $32.93	$493.50M	1.06	192,625 shs	103,657 shs

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AORT Artivion	0.00%	-6.31%	-4.91%	+41.85%	+61.11%
ENOV Enovis	0.00%	-0.92%	+7.58%	-1.40%	-26.63%
EYE National Vision	0.00%	-2.09%	+1.14%	+2.86%	+111.31%
KIDS OrthoPediatrics	0.00%	-6.03%	+2.40%	-6.92%	-39.13%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AORT Artivion	$39.89 -2.0%	$37.46	$21.97 ▼ $45.07	$1.88B	1.69	441,917 shs	124,466 shs
ENOV Enovis	$32.02 +0.9%	$29.85	$25.47 ▼ $49.83	$1.83B	1.68	1.17 million shs	438,895 shs
EYE National Vision	$23.67 +2.9%	$24.00	$9.56 ▼ $25.67	$1.88B	1.23	2.08 million shs	731,680 shs
KIDS OrthoPediatrics	$19.67 +0.1%	$20.90	$16.59 ▼ $32.93	$493.50M	1.06	192,625 shs	103,657 shs

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AORT Artivion	0.00%	-6.31%	-4.91%	+41.85%	+61.11%
ENOV Enovis	0.00%	-0.92%	+7.58%	-1.40%	-26.63%
EYE National Vision	0.00%	-2.09%	+1.14%	+2.86%	+111.31%
KIDS OrthoPediatrics	0.00%	-6.03%	+2.40%	-6.92%	-39.13%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AORT Artivion	3.00	Buy	$40.63	1.88% Upside
ENOV Enovis	3.00	Buy	$51.00	59.30% Upside
EYE National Vision	2.60	Moderate Buy	$24.73	4.49% Upside
KIDS OrthoPediatrics	2.88	Moderate Buy	$34.14	73.58% Upside

Current Analyst Ratings Breakdown

Latest KIDS, AORT, EYE, and ENOV Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/22/2025	AORT Artivion	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$45.00 ➝ $50.00
8/13/2025	AORT Artivion	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$32.00 ➝ $38.80
8/8/2025	AORT Artivion	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform
8/8/2025	KIDS OrthoPediatrics	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Market Outperform	$50.00 ➝ $35.00
8/8/2025	KIDS OrthoPediatrics	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Outperform
8/8/2025	AORT Artivion	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$35.00 ➝ $41.00
8/8/2025	AORT Artivion	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Market Outperform	$33.00 ➝ $42.00
8/8/2025	AORT Artivion	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$36.00 ➝ $40.00
8/8/2025	AORT Artivion	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$32.00 ➝ $45.00
8/8/2025	ENOV Enovis	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$70.00 ➝ $58.00
8/8/2025	ENOV Enovis	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$65.00 ➝ $57.00

(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AORT Artivion	$388.54M	4.84	$0.82 per share	48.78	$6.59 per share	6.05
ENOV Enovis	$2.11B	0.87	$19.40 per share	1.65	$45.10 per share	0.71
EYE National Vision	$1.82B	1.03	$1.68 per share	14.05	$10.37 per share	2.28
KIDS OrthoPediatrics	$204.73M	2.41	N/A	N/A	$14.64 per share	1.34

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AORT Artivion	-$13.36M	-$0.42	N/A	79.77	N/A	-4.43%	5.70%	2.29%	11/6/2025 (Estimated)
ENOV Enovis	-$825.49M	-$14.25	N/A	10.04	N/A	-37.80%	6.78%	3.73%	11/5/2025 (Estimated)
EYE National Vision	-$28.50M	-$0.18	N/A	87.65	2.71	-0.75%	3.56%	1.49%	11/5/2025 (Estimated)
KIDS OrthoPediatrics	-$37.82M	-$1.79	N/A	N/A	N/A	-18.92%	-6.36%	-4.69%	11/5/2025 (Estimated)

Latest KIDS, AORT, EYE, and ENOV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	AORT Artivion	$0.11	$0.24	+$0.13	$0.03	$107.96 million	$112.97 million
8/7/2025	Q2 2025	ENOV Enovis	$0.74	$0.79	+$0.05	-$0.64	$555.80 million	$564.50 million
8/6/2025	Q2 2025	EYE National Vision	$0.12	$0.18	+$0.06	$0.11	$469.21 million	$486.42 million
8/5/2025	Q2 2025	KIDS OrthoPediatrics	-$0.17	-$0.11	+$0.06	-$0.30	$61.40 million	$61.08 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AORT Artivion	N/A	N/A	N/A	N/A	N/A
ENOV Enovis	N/A	N/A	N/A	N/A	N/A
EYE National Vision	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AORT Artivion	0.52	4.78	3.48
ENOV Enovis	0.53	2.25	1.15
EYE National Vision	0.30	0.52	0.31
KIDS OrthoPediatrics	0.27	6.66	3.43

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AORT Artivion	86.37%
ENOV Enovis	98.45%
EYE National Vision	N/A
KIDS OrthoPediatrics	69.05%

Insider Ownership

Company	Insider Ownership
AORT Artivion	8.10%
ENOV Enovis	2.70%
EYE National Vision	2.70%
KIDS OrthoPediatrics	31.80%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AORT Artivion	1,600	47.18 million	43.36 million	Optionable
ENOV Enovis	7,367	57.16 million	55.62 million	Optionable
EYE National Vision	13,411	79.20 million	77.06 million	Optionable
KIDS OrthoPediatrics	200	25.07 million	17.10 million	Optionable

KIDS, AORT, EYE, and ENOV Headlines

Recent News About These Companies

Brokerages Set OrthoPediatrics Corp. (NASDAQ:KIDS) PT at $34.14

September 13 at 2:36 AM | americanbankingnews.com

OrthoPediatrics Corp. (NASDAQ:KIDS) Receives Consensus Recommendation of "Moderate Buy" from Analysts

September 12 at 4:49 AM | marketbeat.com

OrthoPediatrics Corp. (NASDAQ:KIDS) Given Consensus Recommendation of "Moderate Buy" by Analysts

September 12 at 4:33 AM | marketbeat.com

OrthoPediatrics’ spinal growth system debuts

September 10, 2025 | beckersspine.comB

OrthoPediatrics announces completion of first procedures with VerteGlide system

September 10, 2025 | msn.com

OrthoPediatrics Completes First U.S. Surgeries with VerteGlide Spinal Growth Guidance System for Early Onset Scoliosis

September 10, 2025 | quiverquant.comQ

OrthoPediatrics Corp. Completes First Procedures with VerteGlide™ Spinal Growth Guidance System

September 10, 2025 | globenewswire.com

Granahan Investment Management LLC Has $16.43 Million Stock Holdings in OrthoPediatrics Corp. $KIDS

September 7, 2025 | marketbeat.com

AWM Investment Company Inc. Buys 28,488 Shares of OrthoPediatrics Corp. $KIDS

September 5, 2025 | marketbeat.com

OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc.

September 5, 2025 | globenewswire.com

20,000 Shares in OrthoPediatrics Corp. $KIDS Purchased by Birchview Capital LP

September 4, 2025 | marketbeat.com

Nuveen LLC Takes Position in OrthoPediatrics Corp. $KIDS

September 4, 2025 | marketbeat.com

OrthoPediatrics Corp. $KIDS Shares Bought by Paradigm Capital Management Inc. NY

September 2, 2025 | marketbeat.com

Vanguard Group Inc. Has $23.10 Million Stock Holdings in OrthoPediatrics Corp. $KIDS

August 31, 2025 | marketbeat.com

OrthoPediatrics (NASDAQ:KIDS) CFO Buys $98,525.16 in Stock

August 27, 2025 | marketbeat.com

OrthoPediatrics (NASDAQ:KIDS) CFO Fred Hite Purchases 5,076 Shares

August 26, 2025 | insidertrades.com

OrthoPediatrics Corp. Appoints Kelly Fischer to Board of Directors, Following Retirement of Terry Schlotterback

August 25, 2025 | quiverquant.comQ

OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors

August 25, 2025 | globenewswire.com

OrthoPediatrics Corp. (NASDAQ:KIDS) Given Average Rating of "Moderate Buy" by Brokerages

August 17, 2025 | marketbeat.com

Citizens JMP Slashes PT on OrthoPediatrics (KIDS) to $35 From $50, Keeps an Outperform Rating

August 13, 2025 | msn.com

Analysts Offer Insights on Healthcare Companies: OrthoPediatrics (KIDS) and Alcon (ALC)

August 8, 2025 | theglobeandmail.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

KIDS, AORT, EYE, and ENOV Company Descriptions

Artivion NYSE:AORT

$39.88 -0.82 (-2.00%)

As of 02:40 PM Eastern

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

Enovis NYSE:ENOV

$32.02 +0.30 (+0.93%)

As of 02:40 PM Eastern

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

National Vision NASDAQ:EYE

$23.66 +0.68 (+2.94%)

As of 02:40 PM Eastern

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

OrthoPediatrics NASDAQ:KIDS

$19.67 +0.02 (+0.10%)

As of 02:39 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest KIDS, AORT, EYE, and ENOV Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest KIDS, AORT, EYE, and ENOV Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

KIDS, AORT, EYE, and ENOV Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

KIDS, AORT, EYE, and ENOV Company Descriptions

Artivion NYSE:AORT

Enovis NYSE:ENOV

National Vision NASDAQ:EYE

OrthoPediatrics NASDAQ:KIDS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest KIDS, AORT, EYE, and ENOV Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest KIDS, AORT, EYE, and ENOV Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

KIDS, AORT, EYE, and ENOV Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

KIDS, AORT, EYE, and ENOV Company Descriptions

Artivion NYSE:AORT

Enovis NYSE:ENOV

National Vision NASDAQ:EYE

OrthoPediatrics NASDAQ:KIDS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools